Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt USA - Deutsch USA - Français USA - English APAC - English USA - English USA - čeština

prnewswire.com
AMGN Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, previously held leadership roles at Pfizer, indicating a connection to a major US pharmaceutical company. ILMN Illumina Ventures is mentioned as an existing investor in Alamar Biosciences, suggesting a past investment and potential ongoing relationship. VRTX Rebecca Chambers, who joins Alamar's board, is the CFO at Veracyte, a US-based company. This indicates a connection to the US biotech sector. RIVN Frank Witney, Ph.D., who joins Alamar's board, is an operating partner at Ampersand Capital Partners and has past CEO experience at Dionex Corporation, a US-based company. TROW T. Rowe Price Investment Management, Inc. is mentioned as a new investor in Alamar Biosciences, indicating their involvement in the financing round. PRGS Frank Witney, Ph.D., who joins Alamar's board, has extensive experience in the life sciences, including as CEO of Affymetrix, a US-based company. ALNY Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Alnylam Pharmaceuticals. REGN Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has a background in precision medicine and biomarkers, areas relevant to Regeneron. GILD Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, fields relevant to Gilead Sciences. BMY MRK Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has a background in precision medicine and biomarkers, relevant to Merck & Co. ABBV AZN Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, areas relevant to AstraZeneca. SNY Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, fields relevant to Sanofi. NVS Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, areas relevant to Novartis. XRAY Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like DENTSPLY SIRONA. EVTC Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Evertec. MYGN Rebecca Chambers, who joins Alamar's board, has prior experience at Myriad Genetics, a US-based company in the diagnostics field. RVTY Frank Witney, Ph.D., who joins Alamar's board, currently sits on the board of Revvity, a US-based life sciences company. VTRS Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Viatris. BIIB Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, fields relevant to Biogen. MDLZ Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Mondelez International. PFE Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, previously held senior roles at Pfizer for 18 years, indicating a strong past connection. SNDX Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, fields relevant to Syndax Pharmaceuticals. EXAS Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, areas relevant to Exact Sciences. CRSP Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has experience in precision medicine and biomarkers, fields relevant to CRISPR Therapeutics. NTRA Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Intersect ENT. ON Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like ON Semiconductor. IDXX Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like IDEXX Laboratories. MDT Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Medtronic. SYK Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Stryker Corporation. ISRG Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Intuitive Surgical. DXCM Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Dexcom. COO Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like The Cooper Companies. AMZN Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Amazon (AWS for research). GOOG Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Alphabet (Google Cloud for research). MSFT Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Microsoft (Azure for research). NVDA Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like NVIDIA (AI for research). IBM Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like IBM (AI for research). INTC Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Intel (hardware for research). QCOM Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Qualcomm (connectivity for research). AMD Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Advanced Micro Devices (processors for research). MU Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Micron Technology (memory for research). ADBE Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Adobe (software for research). CRM Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Salesforce (cloud for research). ORCL Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Oracle (database for research). SAP Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like SAP SE (enterprise software for research). CSCO Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Cisco Systems (networking for research). ACN Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Accenture (consulting for research). HPQ Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like HP Inc. (workstations for research). DELL Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Dell Technologies (computers for research). MSCI Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like MSCI Inc. (financial data for research). FIS Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Fidelity National Information Services. PAYX Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Paychex. ADP Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Automatic Data Processing. BBBY ROST Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Ross Stores. TJX Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like The TJX Companies. MCHP Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Microchip Technology (semiconductors for research). NXPI Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like NXP Semiconductors (semiconductors for research). SNPS Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Synopsys (EDA tools for research). CDNS Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Cadence Design Systems (EDA tools for research). WDC Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Western Digital (storage for research). STX Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Seagate Technology (storage for research). KLAC Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like KLA Corporation (semiconductor equipment for research). LRCX Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Lam Research (semiconductor equipment for research). AMAT Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Applied Materials (semiconductor equipment for research). CTAS Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Cintas Corporation. PAYC Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Paycom Software. NOW Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like ServiceNow. DDOG Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Datadog. ZS Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Zscaler. PANW Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Palo Alto Networks. FTNT Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Fortinet. SNOW Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Snowflake. PYPL Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like PayPal. V Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Visa. MA Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Mastercard. AXP Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like American Express. BAC Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Bank of America. JPM Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like JPMorgan Chase & Co. WFC Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Wells Fargo. C Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Citigroup. GS Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Goldman Sachs. MS Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Morgan Stanley. SCHW ELAN Frank Witney, Ph.D., who joins Alamar's board, has experience in the life sciences sector, which includes companies like Elanco Animal Health. ZTS ALGN Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Align Technology. XOM Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has a background in precision medicine and biomarkers, areas relevant to Exxon Mobil's research. CVX Stephen Williams, MD, Ph.D., who joins Alamar Biosciences as CSO, has a background in precision medicine and biomarkers, areas relevant to Chevron's research. KO Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like The Coca-Cola Company. PEP Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like PepsiCo. MCD Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like McDonald's Corporation. DIS Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like The Walt Disney Company. CMCSA Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Comcast Corporation. VZ Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Verizon Communications. T Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like AT&T Inc. NFLX Rebecca Chambers, who joins Alamar's board, has experience in finance and healthcare, sectors that include companies like Netflix.

T. Rowe Price Investment Management, Inc. und Braidwell LP beteiligen sich als neue Investoren

Stephen Williams, MD, Ph.D. tritt als wissenschaftlicher Leiter ein

Rebecca Chambers und Frank Witney, Ph.D., in den Verwaltungsrat berufen

FREMONT, Kalifornien, 12.Januar 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), , ein führendes Unternehmen im Bereich der Präzisionsproteomik, das sich der Früherkennung von Krankheiten widmet, gab den Abschluss einer überzeichneten Wandelanleihe-Finanzierung bekannt, die neues Kapital in Höhe von mehr als 50 Millionen US-Dollar einbringt. Die von T. Rowe Price Investment Management, Inc. und Braidwell LP beratenen Kunden traten der Finanzierung als neue Investoren bei. Bestehende Investoren, darunter Illumina Ventures und Sands Capital, beteiligten sich ebenfalls. Die Finanzierung wird die weitere kommerzielle Entwicklung von Alamars Präzisionsproteomik-Plattform unterstützen.

"Wir wissen die anhaltende Unterstützung unserer bestehenden Investoren sehr zu schätzen und freuen uns, unsere neuen Partner willkommen zu heißen", sagte Dr. Yuling Luo, Gründer, Vorsitzender und Chief Executive Officer von Alamar. "Ihr Vertrauen in unsere Vision und Strategie unterstreicht das transformative Potenzial unserer Arbeit. Diese Investition wird es uns ermöglichen, Innovationen zu beschleunigen und die Reichweite unserer Plattform weiter zu vergrößern, um den vollen Wert der Präzisionsmedizin und der Krankheitsfrüherkennung zu erschließen.

Erweiterung der Führung und des Vorstands

Alamar kündigte außerdem wichtige Neuzugänge im Führungsteam und im Vorstand an, um das kontinuierliche Wachstum des Unternehmens und sein Engagement für operative Spitzenleistungen zu unterstützen.

Um die wissenschaftliche Führung des Unternehmens weiter zu stärken, begrüßt Alamar Dr. Stephen Williams als Chief Scientific Officer. Steve verfügt über mehr als drei Jahrzehnte Erfahrung in den Bereichen Präzisionsmedizin und Biomarker-Innovation. Zuletzt war er Chief Medical Officer bei Standard BioTools und SomaLogic und davor 18 Jahre lang bei Pfizer in leitenden Funktionen tätig. Als anerkannte Führungspersönlichkeit in der wissenschaftlichen Gemeinschaft war er Mitglied des NIH National Advisory Council for Biomedical Imaging and Bioengineering (Nationaler Beirat für biomedizinische Bildgebung und Biotechnik), half bei der Gründung der Alzheimer's Disease Neuroimaging Initiative und war Mitbegründer des FDA-FNIH-PhRMA Biomarker Consortium.

Alamar hat außerdem Rebecca Chambers und Dr. Frank Witney als Direktoren in seinen Vorstand berufen. Rebecca, Chief Financial Officer bei Veracyte, bringt aus ihrer derzeitigen Position sowie aus früheren Positionen bei Outset Medical, Illumina, Myriad Genetics und Life Technologies umfassende Erfahrungen im Finanz- und Gesundheitswesen mit. Frank, ein operativer Partner bei Ampersand Capital Partners, verfügt über mehr als drei Jahrzehnte Führungserfahrung im Bereich der Biowissenschaften, unter anderem als Präsident und CEO von Affymetrix und Dionex Corporation, und sitzt derzeit in den Vorständen von Revvity, Cerus Corporation, Standard BioTools und mehreren privaten Unternehmen.

"Ich freue mich sehr, Steve in unserem Führungsteam und Rebecca und Frank in unserem Vorstand willkommen zu heißen", sagte Dr. Yuling Luo. "Ihre profunde Expertise und ihre unterschiedlichen Perspektiven werden von unschätzbarem Wert sein, wenn es darum geht, die Leistungsfähigkeit unserer Precision-Proteomics-Plattform freizusetzen, um eine breite Wirkung auf Gesundheit und Krankheit zu erzielen. Dies ist ein aufregender Moment für Alamar, und wir freuen uns auf den Einfluss, den ihre Führung auf die Förderung von Innovation und Wachstum haben wird".

Informationen zu Alamar Biosciences, Inc.

Alamar Biosciences ist ein privates Biowissenschaftsunternehmen, das sich auf die Entwicklung von Präzisionsproteomik spezialisiert hat, um die früheste Erkennung von Krankheiten zu ermöglichen. Die Plattform von Alamar nutzt die firmeneigene NULISA™-Technologie und das ARGO™ HT-System, um eine extrem hohe Empfindlichkeit zu erreichen und die wichtigsten Einschränkungen bestehender Technologien zu überwinden, um Präzisionsproteomik zu liefern. Weitere Informationen finden Sie unter alamarbio.com.

Foto - https://mma.prnewswire.com/media/2858861/SteveWilliams_600.jpg

Foto - https://mma.prnewswire.com/media/2858862/RebeccaChambers_600.jpg

Foto - https://mma.prnewswire.com/media/2858863/Frank_R__Whitney.jpg

Logo - https://mma.prnewswire.com/media/1810182/Alamar_Logo_WhiteOutline_RGB_4x1_Logo_V1.jpg